NCT04222478 Interest of Auriculotherapy in the Treatment of Xerostomia
| NCT ID | NCT04222478 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Hopital Foch |
| Condition | Xerostomia |
| Study Type | INTERVENTIONAL |
| Enrollment | 68 participants |
| Start Date | 2019-12-04 |
| Primary Completion | 2025-12-04 |
Trial Parameters
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
Brief Summary
The aim of the study is to show that auriculotherapy is effective in the treatment of xerostomia
Eligibility Criteria
Inclusion Criteria: * Patients over 18 years old; * Complain about xerostomia after cervical irradiation in the context of ENT cancer; * End of radiotherapy\> 3 months * Covered by a national healthcare insurance * Consent form signed. Non inclusion Criteria: * Pregnant or breastfeeding women; * Local counterindication to auriculotherapy; * With anticoagulant treatment; * History or existing of hemophilia; * Valvular prosthesis; * Ear's pavilion infection; * Treatment by auriculotherapy or acupuncture in this indication in the previous 12 months; * Having started in the 48 hours preceding the first auriculotherapy session, any new management of xerostomia and likely to interfere with the study (specific medication and/or complementary therapeutic management); * Difficulty to comply with the treatment, questionnaires or study protocol; * Being deprived of liberty or under guardianship.